A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight

NCT06388187 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo

Sponsor

Novo Nordisk A/S